Synapse Open Synapse
Patents & IP

Examining the Bolar exemption and TRIPS compliance in Türkiye as new EU Pharma Package seeks to broaden exemption

IAM · · 4 min read

Amid the entry of the EU Pharma Package, which aims to broaden the Bolar exemption substantially both in terms of the activities covered and the parties entitled to rely on it, a re-examination of Türkiye’s longstanding interpretation of the Bolar exemption is essential for rights holders.

Latest from IAM